ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 92909 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 92909; 2) Community: the network communities that were significantly associated with the response to NSC 92909; 3) Molecule: the relationships between components within communities and NSC 92909; 4) MDR: the compounds that were significantly associated with the NSC 92909.

NSC Compound Enrichment Correlation
NSC 718564 Null 0.0348993771550531 0.27089782
NSC 718781 Erlotinib hydrochloride 0.0348993771550531 -0.12979617
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0348993771550531 0.1364578
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0348993771550531 -0.045199564
NSC 734287 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0348993771550531 0.22885151
NSC 755442 Null 0.0348993771550531 0.14088748
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0348993771550531 -0.080594395
NSC 113951 6-Bromotoyocamycin 0.0350615470435428 0.27789191
NSC 330500 Macbecin II 0.0350615470435428 0.20723194
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0350615470435428 0.37881186
Total:37  Current:23    [First] [Prev] [Next] [Last]